A detailed history of Monarch Partners Asset Management LLC transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Monarch Partners Asset Management LLC holds 35,645 shares of PRTA stock, worth $507,228. This represents 0.65% of its overall portfolio holdings.

Number of Shares
35,645
Previous 33,360 6.85%
Holding current value
$507,228
Previous $2.02 Million 6.13%
% of portfolio
0.65%
Previous 0.61%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 02, 2023

BUY
$52.05 - $65.0 $118,934 - $148,525
2,285 Added 6.85%
35,645 $2.15 Million
Q3 2022

Oct 31, 2022

BUY
$25.16 - $60.63 $839,337 - $2.02 Million
33,360 New
33,360 $2.02 Million

Others Institutions Holding PRTA

About PROTHENA CORP PUBLIC LTD CO


  • Ticker PRTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,922,800
  • Market Cap $668M
  • Description
  • Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...
More about PRTA
Track This Portfolio

Track Monarch Partners Asset Management LLC Portfolio

Follow Monarch Partners Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Monarch Partners Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Monarch Partners Asset Management LLC with notifications on news.